Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016

Figures & data

Figure 1 Cervical screening outcomes by year.

Abbreviations: ASCUS, atypical squamous cell of undetermined significance; LGSIL, low-grade squamous intraepithelial lesions; HPV, human papilloma virus.

Table 1 Characteristics of women by cervical cancer screening status, 2016

Characteristics	Cervical cancer screening			P-value
	Yes, n (%)	No, n (%)	Total, N (%)
Age (years)				0.6699
≤40	24 (9)	11 (12)	35 (10)
41–50	80 (29)	22 (24)	102 (28)
51–60	103 (38)	34 (38)	137 (38)
≥61	63 (24)	23 (26)	86 (24)
Race/ethnicity				0.7912
Hispanic	45 (17)	22 (24)	67 (19)
African American	216 (80)	62 (69)	278 (77)
Other	9 (3)	6 (7)	15 (4)
Transmission risk				1.0000
Heterosexual	234 (87)	78 (87)	312 (87)
Injection drug use	36 (13)	12 (13)	48 (13)
Housing				0.1114
Private	217 (80)	79 (88)	296 (82)
Public	53 (20)	11 (12)	64 (18)
Income				0.8898
≤FPLa	200 (74)	66 (73)	266 (74)
>FPLa	70 (26)	24 (27)	94 (26)
Insurance				0.7425
Medicaid	126 (47)	44 (49)	170 (47)
Medicare	133 (49)	41 (46)	174 (48)
Other	11 (4)	5 (5)	16 (5)
History of drug use				0.3043
Cocaine	38 (14)	12 (13)	50 (14)
Heroin	11 (4)	2 (2)	13 (4)
Both	69 (26)	16 (18)	85 (24)
Never	152 (56)	60 (67)	212 (58)
History of mental illness				0.1055
Yes	113 (42)	29 (32)	142 (39)
No	157 (58)	61 (68)	218 (61)
Care status				0.0663
Current	230 (85)	67 (74)	297 (83)
Newly diagnosed	8 (3)	5 (6)	13 (3)
Reengaged	32 (12)	18 (20)	50 (14)
Prior screening				<0.0001
Yes	241 (82)	52 (18)	293 (81)
No	29 (43)	38 (57)	67 (19)
Total
2016	270 (75)	90 (25)	360

Note:

a FPL for one person in 2016 was ≥11,770.

Abbreviation: FPL, federal poverty limit.

Table 2 Adjusted odds for cervical cancer screening, Peter Ho Clinic, 2016

Characteristic	Odds ratio (95% CI)	Adjusted odds ratio (95% CI)a
Prior screening
Yes	6.07 (3.44–10.72)	6.88 (3.47–13.67)
No	1.00	1.00

Note:

a Model adjusted for age, race, insurance, risk, housing, federal poverty limit for 2016, drug use, and mental illness.